The key to stopping the progress of and eliminating such diseases is the control of transmission of infectious tropical diseases such as malaria by containing or reducing vectors. This can only be done with suitable insecticides, formulations (e.g. ‘space sprays’) and forms of application (e.g. in mosquito nets).
With the aim of mastering the associated challenges and accelerating the development of resistance-free products suitable for controlling malaria, Bayer has entered a public private partnership with the Innovative Vector Control Consortium (IVCC), an organization based in Liverpool, United Kingdom, which is funded by the Bill and Melinda Gates Foundation.